Results 31 to 40 of about 5,339,936 (244)

Concurrent Detection of Circulating Tumor Cells and Circulating Tumor DNA in Triple-negative Breast Cancer

open access: yesAsian Pacific Journal of Cancer Care, 2021
Objective: Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) provide tumor information in breast cancer. Our objective was to characterize CTCs, and contrasted them with ctDNA PIK3CA mutation in 24 triple-negative breast cancer (TNBC ...
Henry L Gomez   +11 more
doaj   +1 more source

Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?

open access: yesClinical and Experimental Obstetrics & Gynecology, 2023
This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to ...
Felix Wong   +2 more
doaj   +1 more source

Isolation and characterization of circulating tumor cells in prostate cancer

open access: yesFrontiers in Oncology, 2012
Circulating tumor cells (CTCs) are tumor cells found in the peripheral blood that originate from established sites of malignancy and likely have metastatic potential. Analysis of circulating tumor cells CTCs has shown great promise as a prognostic marker
Elan Shlomo Diamond   +6 more
doaj   +1 more source

Feasibility of Genetic Aberrations Analysis in the Circulating Tumor Cells (CTCS)

open access: yesAnnals of Oncology, 2012
ABSTRACT Background In current practice cancer tissue is taken at diagnosis to assess the presence of treatment targets. This however is suboptimal since tumor cells evolve due to genomic instability. Assessment of the genotype and phenotype of the CTCs will provide insights into which treatments would be most beneficial for the individual patient ...
Antonello, J.   +8 more
openaire   +2 more sources

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity

open access: yesFrontiers in Oncology, 2022
PurposeTo investigate the role of circulating rare cells (CRCs), namely, circulating tumor cells (CTCs) and circulating endothelial cells (CECs), in aiding early intervention, treatment decision, and prognostication in bladder cancer.MethodsA total of ...
Xiao Yang   +14 more
doaj   +1 more source

Circulating tumor cells as prognostic biomarkers in glioblastoma.

open access: yes, 2021
Background: Glioblastoma (GBM) is the most common and aggressive type of tumor arising from the central nervous system. GBM remains an incurable disease despite current advancement in therapies, with survival rates of approximately 15 months.
Chua, Benjamin   +8 more
core   +1 more source

Circulating Tumor Cells (CTCs): From Detection to Dissection

open access: yesJBR Journal of Clinical Diagnosis and Research, 2015
Summary 䀆e breast cancer represents one of the most prevalent cancers in the world. 䀆e outlook for patients diagnosed with breast cancer has been changing for the better over time, with several sgnficant advances coming through in the past 10 years; among them, and a 怇er highlighting the importance of prevention and early diagnosis, relevant advances
Serrano MJ, Garcia puche JL
openaire   +1 more source

Circulating Tumor Cells (CTC) and Tumor-Derived Extracellular Vesicles (tdEV)

open access: yes, 2023
The observation that increasing circulating tumor cell (CTC) and tumor-derived extracellular vesicle (tdEV) load is directly related to worse clinical outcome of cancer patients is in line with expectations. However, both CTC and tdEV exhibit inter- and intra-patient heterogeneity, and the puzzle is yet to be deciphered in regard to the phenotype of ...
Nanou, A.   +3 more
openaire   +2 more sources

A New Method for CTC Images Recognition Based on Machine Learning

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Circulating tumor cells (CTCs) derived from primary tumors and/or metastatic tumors are markers for tumor prognosis, and can also be used to monitor therapeutic efficacy and tumor recurrence.
Binsheng He   +13 more
doaj   +1 more source

Identification and gene expression analysis of circulating tumor cells with high expression of KRAS in pancreatic cancer

open access: yesAIP Advances, 2023
This study aims to establish a highly sensitive and specific method for single cell screening and identification of KRAS+/epithelial cell adhesion molecules (EpCAMs)/vimentin+/pancreatic cancer circulating tumor cells (CTCs) and to explore the clinical ...
Zhiqiang Zheng   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy